Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...

Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success.

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far along are they?

Discover how AI and ML are already shaping therapeutic antibody discovery and explore their future potential.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee?

Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging few years.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.